Finance

Lists
Q3 2026 earnings • released • EPS beat +५.५६% • Revenue beat +०.१४%
See results
COLL:NASDAQ
Collegium Pharmaceutical Inc
US$ २५.१६
+६.२९%
(+१.४९) 1D
US$ २४.४६
-२.७८% (-०.७०)
After hours
Closed: नोभेम्बर ५, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COLL...
Open
US$ २५.७४
High
US$ २६.३९
Low
US$ २४.३२
Mkt. cap
८१.९१ करोड
Avg. vol.
६.७१ लाख
Volume
०.००
P/E ratio
२०.४९
52-wk high
US$ ५०.७९
52-wk low
US$ २१.४३
EPS
US$ १.२३
Beta
०.७५
Shares outstanding
३.२६ करोड
No. of employees
४२३
Open
US$ २५.७४
High
US$ २६.३९
Low
US$ २४.३२
Mkt. cap
८१.९१ करोड
Avg. vol.
६.७१ लाख
Volume
०.००
P/E ratio
२०.४९
52-wk high
US$ ५०.७९
52-wk low
US$ २१.४३
EPS
US$ १.२३
Beta
०.७५
Shares outstanding
३.२६ करोड
No. of employees
४२३
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
७ घण्टा पहिले
Collegium Pharmaceutical, Inc. Q3 2026 Earnings Call Summary
Traders Union
Traders Union
·
१५ घण्टा पहिले
Collegium Pharmaceutical posts record Q3 2026 revenue as stock rises 9%
TradingView
TradingView
·
१५ घण्टा पहिले
Collegium Pharmaceutical Q3 Earnings Call Highlights
TradingView
TradingView
·
१५ घण्टा पहिले
Collegium Pharmaceutical, Inc. reports results for the quarter ended September 30 - Earnings Summary
About Collegium Pharmaceutical Inc
CEO-
Employees४२३
Founded२००२
Headquarters-
SectorHealth Care
Industry-
Websitecollegiumpharma.com
Analyst ratings
Based on 7 analysts giving stock ratings to COLL in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for COLL in the last 3 months.
Highest
Current US$ २५.१६
US$ ६०.०० (+१३८.४७%)
Average
US$ ४८.७१ (+९३.६०%)
Lowest
US$ ४३.०० (+७०.९१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jenna Davidner
Barclays
Buy
Maintained
US$ ४८.००
+९०.८%
10/15/2026
Les Sulewski
Oppenheimer
Buy
Reiterated
US$ ५०.००
+९८.७%
10/09/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
US$ ५०.००
+९८.७%
09/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
US$ ६०.००
+१३८.५%
09/21/2026
Daniel Clark
Leerink Partners
Buy
Initiated
US$ ४५.००
+७८.९%
09/09/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
US$ ४९.००
+९४.८%
09/09/2026
Alexander Xenakis
Truist Financial
Buy
Initiated
US$ ४९.००
+९४.८%
09/09/2026
David Amsellem
Piper Sandler
Hold
Reiterated
US$ ४३.००
+७०.९%
08/07/2026
Serge Belanger
Needham
Buy
Maintained
US$ ४६.००
+८२.८%
08/06/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ५१.००
+१०२.७%
03/20/2026
Last report
२०२६ नोभेम्बर ५
Fiscal period
Q3 2026
US$ १.९६ / US$ १.८६
+५.५६%beat
Revenue / Est. (USD)
२१.६३ करोड / २१.६० करोड
+०.१४%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२०.९४ करोड
२०.५४ करोड
१९.३५ करोड
१९.९९ करोड
Cost of goods sold
२.१७ करोड
२.१६ करोड
२.०८ करोड
२.१२ करोड
Cost of revenue
२.१७ करोड
२.१६ करोड
२.०८ करोड
२.१२ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.५६ करोड
६.६७ करोड
८.६४ करोड
१०.४४ करोड
Operating expense
१२.१० करोड
१२.२१ करोड
१४.१८ करोड
१६.७४ करोड
Total operating expenses
१४.२७ करोड
१४.३७ करोड
१६.२६ करोड
१८.८६ करोड
Operating income
६.६७ करोड
६.१७ करोड
३.०९ करोड
१.१३ करोड
Other non operating income
-
-
-
-
EBT including unusual items
४.३४ करोड
२.९० करोड
१.८७ करोड
-१.३५ करोड
EBT excluding unusual items
४.८० करोड
४.६० करोड
१.८७ करोड
-५९.३३ लाख
Income tax expense
१.१९ करोड
१.२१ करोड
४२.४४ लाख
१५.१९ लाख
Effective tax rate
२७.४६%
४१.५८%
२२.६५%
-११.२३%
Other operating expenses
-
-
-
-
Net income
३.१५ करोड
१.७० करोड
१.४५ करोड
-१.५१ करोड
Net profit margin
१५.०५%
८.२६%
७.४९%
-७.५३%
Earnings per share
२.२५
२.०४
१.७६
१.९२
Interest and investment income
३१.१६ लाख
३५.६५ लाख
३७.०६ लाख
२२.८९ लाख
Interest expense
-२.१८ करोड
-१.९३ करोड
-१.५९ करोड
-१.९५ करोड
Net interest expenses
-१.८७ करोड
-१.५७ करोड
-१.२२ करोड
-१.७२ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१२.३२ करोड
११.८१ करोड
८.६८ करोड
७.६१ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू